Basic Information

Terpenoid ID TKC016418
Chirality TKC016414
Cell line 0
Protein target 11
DiseaseNCIT 0
ORDO 0
ICD 43

Active subnetwork


Terpenoid-cell-disease Activity Association

ID Cell Line Synonyms Value Unit Type NCIt ORDO
TKC016418 MDA-N MDAN 9311.0 nM GI50 C3802
TKC016418 SN12C SN-12C 15205.0 nM GI50 C9385 Orphanet_217071
TKC016418 ACHN 28973.0 nM GI50 C6975 Orphanet_319298
TKC016418 NCI-H23 NCI.H23; NCI H23; H-23; H23; NCIH23 21577.0 nM GI50 C3512
TKC016418 UO-31 UO.31; UO31; U031 36308.0 nM GI50 C9385 Orphanet_217071
TKC016418 HOP-92 HOP 92; HOP.92; HOP92; Hop92; Hopkins-92 27797.0 nM GI50 C2926
TKC016418 HL-60 HL 60; HL.60 HL60; Human Leukemia-60 16181.0 nM GI50 C9154 Orphanet_519
TKC016418 DU-145 DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 38815.0 nM GI50 C4863
TKC016418 SK-MEL-5 SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel 14125.0 nM GI50 C3510
TKC016418 SF-539 SF-539; SF-539 BT; SF.539; SF 539 20606.0 nM GI50 C3796 Orphanet_251576
TKC016418 Malme-3M MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer 15560.0 nM GI50 C3224
TKC016418 K562 K562; K.562; K 562; KO; GM05372; GM05372E 3243.0 nM GI50 C9110 Orphanet_521
TKC016418 A498 A498 32659.0 nM GI50 C9385 Orphanet_217071
TKC016418 OVCAR-3 Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 9397.0 nM GI50 C105555
TKC016418 MOLT-4 Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D 28184.0 nM GI50 C9142 Orphanet_99861
TKC016418 HOP-62 HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 28249.0 nM GI50 C3512
TKC016418 NCI/ADR-RES NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR 25003.0 nM GI50 C105555
TKC016418 OVCAR-8 OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 10069.0 nM GI50 C105555
TKC016418 U-251 U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) 11117.0 nM GI50 C60781 Orphanet_94
TKC016418 OVCAR-5 OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 17140.0 nM GI50 C105555
TKC016418 SNB-19 SNB.19; SNB19; Surgical Neurology Branch-19 54828.0 nM GI50 C60781 Orphanet_94
TKC016418 MDA-MB-231 MDA_MB_231; MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA-231P; MDA231; MDA231-BRE; MB231; MD Anderson-Metastatic Breast-231 26424.0 nM GI50 C5214
TKC016418 SR SR-786; SR786 1007.0 nM GI50 C37193 Orphanet_300895
TKC016418 TK-10 TK.10; TK 10; TK10 52845.0 nM GI50 C4033 Orphanet_319276
TKC016418 SW-620 SW-620; SW 620; SW.620 9705.0 nM GI50 C4349
TKC016418 KM12 KM-12; KM.12 14125.0 nM GI50 C4910
TKC016418 NCI-H522 NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 10447.0 nM GI50 C3512
TKC016418 M14 M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 17783.0 nM GI50 C3802
TKC016418 NCI-H322M NCI.H322M; H322M; H-322M; H-322m 28973.0 nM GI50 C2923
TKC016418 RPMI-8226 RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson 5420.0 nM GI50 C3242 Orphanet_29073
TKC016418 OVCAR-4 OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 11066.0 nM GI50 C105555
TKC016418 LOX IMVI LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX 12560.0 nM GI50 C3802
TKC016418 BT-549 BT 549; BT.549; BT549 7534.0 nM GI50 C4194
TKC016418 SK-MEL-2 SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 15241.0 nM GI50 C3224
TKC016418 HCC 2998 HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 22542.0 nM GI50 C4349
TKC016418 A549 23823.0 nM GI50 C3512
TKC016418 SNB-75 SNB.75; SNB75; Surgical Neurology Branch-75 15382.0 nM GI50 C3058 Orphanet_360
TKC016418 HCT-15 HCT-15; HCT.15; HCT15 14622.0 nM GI50 C4349
TKC016418 HCT-116 HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 14689.0 nM GI50 C4910
TKC016418 SF-268 SF-268; SF.268; SF 268 31117.0 nM GI50 C60781 Orphanet_94
TKC016418 EKVX 29309.0 nM GI50 C3512
TKC016418 MCF7 15704.0 nM GI50 C4194
TKC016418 PC-3 PC3; PC.3 20091.0 nM GI50 C4863
TKC016418 SK-OV-3 SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 24044.0 nM GI50 C7978
TKC016418 T47D 24660.0 nM GI50 C4194
TKC016418 NCI-H460 NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 21232.0 nM GI50 C4450
TKC016418 UACC-62 UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 18793.0 nM GI50 C3224
TKC016418 SF-295 SF-295; SF.295; SF 295 19861.0 nM GI50 C3058 Orphanet_360
TKC016418 MDA-MB-435 MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435; MD Anderson-Metastatic Breast-435 10328.0 nM GI50 C3802
TKC016418 IGROV-1 Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P 18197.0 nM GI50 C7979 Orphanet_454723
TKC016418 Hs-578T HS 578T; Hs-578T; HS-578T; Hs_578t; Hs-578-T; HS-578-T; Hs 578.T; HS578T; Hs578T; Hs578t; HS0578T; 578T; HS578; Hs578; Homo sapiens No. 578, tumor cells 36559.0 nM GI50 C4194
TKC016418 786-0 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT 5395.0 nM GI50 C9385 Orphanet_217071
TKC016418 UACC-257 UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 19999.0 nM GI50 C3224
TKC016418 CCRF-CEM CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C 3873.0 nM GI50 C7953 Orphanet_99861
TKC016418 HT-29 HT 29; HT29 5284.0 nM GI50 C4349
TKC016418 NCI-H226 NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 39811.0 nM GI50 C45662 Orphanet_50251
TKC016418 SK-MEL-28 SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 13932.0 nM GI50 C3510
TKC016418 RXF 393 RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL 18707.0 nM GI50 C9385 Orphanet_217071
TKC016418 COLO 205 Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 14757.0 nM GI50 C4349
TKC016418 H4 H-4 32959.0 nM EC50 C60781 Orphanet_94

Terpenoid-protein target Activity Association

ID Uniport Pref_name Gene name value unit type
TKC016418 Q9NUW8 Tyrosyl-DNA phosphodiesterase 1 TDP1 3981 nM Potency
TKC016418 P08684 Cytochrome P450 3A4 CYP3A4 15849 nM Potency
TKC016418 Q16236 Nuclear factor erythroid 2-related factor 2 NFE2L2 35481 nM Potency
TKC016418 Q99700 Ataxin-2 ATXN2 31623 nM Potency
TKC016418 O75496 Geminin GMNN 7308 nM Potency
TKC016418 P01215 Glycoprotein hormones alpha chain CGA 28184 nM Potency
TKC016418 P83916 Chromobox protein homolog 1 CBX1 56234 nM Potency
TKC016418 Q96QE3 ATPase family AAA domain-containing protein 5 ATAD5 16354 nM Potency
TKC016418 O00255 Menin MEN1 39811 nM Potency
TKC016418 P51450 Nuclear receptor ROR-gamma Rorc 12589 nM Potency
TKC016418 P04637 Cellular tumor antigen p53 TP53 15849 nM Potency

Protein target-disease Activity Association

Uniport ID Uniport Name ICD-11
P08684 CP3A4_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P08684 CP3A4_HUMAN Atopic eczema [ICD-11: EA80]
P08684 CP3A4_HUMAN Anxiety disorder [ICD-11: 6B00-6B0Z]
Q16236 NF2L2_HUMAN Ataxic disorder [ICD-11: 8A03]
Q16236 NF2L2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q16236 NF2L2_HUMAN Glaucoma [ICD-11: 9C61]
Q16236 NF2L2_HUMAN Lung cancer [ICD-11: 2C25]
Q16236 NF2L2_HUMAN Macular degeneration [ICD-11: 9B75]
Q16236 NF2L2_HUMAN Melanoma [ICD-11: 2C30]
Q16236 NF2L2_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
Q16236 NF2L2_HUMAN Pulmonary hypertension [ICD-11: BB01]
Q16236 NF2L2_HUMAN Subarachnoid haemorrhage [ICD-11: 8B01]
Q16236 NF2L2_HUMAN Urinary system clinical sympton [ICD-11: MF8Y]
Q16236 NF2L2_HUMAN Non-alcoholic fatty liver disease [ICD-11: DB92]
Q16236 NF2L2_HUMAN Alpha-1-antitrypsin deficiency [ICD-11: 5C5A]
Q16236 NF2L2_HUMAN Motor neuron disease [ICD-11: 8B60]
Q16236 NF2L2_HUMAN Multiple sclerosis [ICD-11: 8A40]
P04637 P53_HUMAN Arterial occlusive disease [ICD-11: BD40]
P04637 P53_HUMAN Lip/oral cavity/pharynx neoplasm [ICD-11: 2B6E]
P04637 P53_HUMAN Metastatic liver/bile duct neoplasm [ICD-11: 2D80]
P04637 P53_HUMAN Transplant rejection [ICD-11: NE84]
P04637 P53_HUMAN Ovarian dysfunction [ICD-11: 5A80]
P04637 P53_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P04637 P53_HUMAN Bladder cancer [ICD-11: 2C94]
P04637 P53_HUMAN Brain cancer [ICD-11: 2A00]
P04637 P53_HUMAN Colorectal cancer [ICD-11: 2B91]
P04637 P53_HUMAN Esophageal cancer [ICD-11: 2B70]
P04637 P53_HUMAN Head and neck cancer [ICD-11: 2D42]
P04637 P53_HUMAN Mature B-cell leukaemia [ICD-11: 2A82]
P04637 P53_HUMAN Myelodysplastic syndrome [ICD-11: 2A37]
P04637 P53_HUMAN Ovarian cancer [ICD-11: 2C73]
P04637 P53_HUMAN Pancreatic cancer [ICD-11: 2C10]
P04637 P53_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P04637 P53_HUMAN Stomach cancer [ICD-11: 2B72]
P04637 P53_HUMAN Cervical cancer [ICD-11: 2C77]
P04637 P53_HUMAN Endometrial cancer [ICD-11: 2C76]
P04637 P53_HUMAN Fallopian tube cancer [ICD-11: 2C74]
P04637 P53_HUMAN Liposarcoma [ICD-11: 2B59]
P04637 P53_HUMAN Malignant haematopoietic neoplasm [ICD-11: 2B33]
P04637 P53_HUMAN Peritoneal cancer [ICD-11: 2C51]
P04637 P53_HUMAN Toxicity [ICD-11: N.A.]
P04637 P53_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]
P04637 P53_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P04637 P53_HUMAN Kidney failure [ICD-11: GB60-GB6Z]
P04637 P53_HUMAN Hearing disorder [ICD-11: AB50-AB57]